Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9149
|
pubmed:dateCreated |
1999-2-9
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
23
|
pubmed:volume |
353
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
328
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9929057-Antineoplastic Agents,
pubmed-meshheading:9929057-Chemotherapy, Adjuvant,
pubmed-meshheading:9929057-Drug Administration Schedule,
pubmed-meshheading:9929057-Humans,
pubmed-meshheading:9929057-Interferons,
pubmed-meshheading:9929057-Melanoma,
pubmed-meshheading:9929057-Skin Neoplasms
|
pubmed:year |
1999
|
pubmed:articleTitle |
Adjuvant therapy of cutaneous melanoma.
|
pubmed:publicationType |
Letter,
Comment
|